Article Versions Notes

Tsukamoto Y, Hirashita Y, Shibata T, Fumoto S, Kurogi S, Nakada C, Kinoshita K, Fuchino T, Murakami K, Inomata M, et al. Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response. Cancers. 2023; 15(16):4104. https://doi.org/10.3390/cancers15164104

Tsukamoto, Yoshiyuki, Yuka Hirashita, Tomotaka Shibata, Shoichi Fumoto, Shusaku Kurogi, Chisato Nakada, Keisuke Kinoshita, Takafumi Fuchino, Kazunari Murakami, Masafumi Inomata, and et al. 2023. "Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response" Cancers 15, no. 16: 4104. https://doi.org/10.3390/cancers15164104

Tsukamoto, Y., Hirashita, Y., Shibata, T., Fumoto, S., Kurogi, S., Nakada, C., Kinoshita, K., Fuchino, T., Murakami, K., Inomata, M., Moriyama, M., & Hijiya, N. (2023). Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response. Cancers, 15(16), 4104. https://doi.org/10.3390/cancers15164104